Bridging the Gap between Science and Clinical Practice in Addiction Medicine
-
Register
- Non-Member - Free!
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
Bridging the Gap between Science and Clinical Practice in Addiction Medicine
Developed in Collaboration with the Agency for Healthcare Research and Quality and the National Institutes of Health
Recorded: Thursday, April 13, 2023 to Sunday, April 16, 2023
On-Demand Session
Overview
This 75-minute on-demand session from the ASAM 54th Annual Conference addresses bidirectional communication between the research community and addiction medicine clinicians.
Please complete the Addiction Medicine Research Priorities Survey to give the presenters your feedback. This session will provide an opportunity for bidirectional communication between federal science funding agencies and clinicians about emergent topics in addiction medicine research and addressing the divide between research and clinical practice. Funding agency representatives will solicit clinicians' feedback on which areas of research should be prioritized to improve clinical practice. Clinicians will learn about opportunities for increasing their participation in research. Participants will also discuss how to include more clinical voices in the shaping of addiction research priorities.
The target audience for this intermediate level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This session addresses the following ACGME Competencies: Medical Knowledge, Practice-based Learning and Improvement
This session addresses the following IOM Competencies:Employ evidence-based practice
Learning Objectives
Upon completion, learners will be able to:
- list at least three current areas of scientific focus from NIAAA, NIDA, and AHRQ.
- describe at least three emergent areas within addiction medicine that practitioners are recommending for future scientific funding initiatives.
- Participants will be able to explain the importance of bidirectional communication between science and clinical practice communities, and its potential to improve quality of care and promote health equity within addiction medicine.
Registration Rates
| Rate Description | Rate |
| ASAM Member | $0 |
| Non-Member | $0 |
| Associate Member | $0 |
| Resident Member* | $0 |
| Student Member* | $0 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 05/15/2026
Session Instructions
- Click on the Contents tab to watch the on-demand recording.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Wilson Compton
MD, MPE
Wilson M. Compton, MD, MPE serves as the Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. In his current role, Dr. Compton's responsibilities include providing scientific leadership in the development, implementation, and management of NIDA's research portfolio and working with the Director to support and conduct research to improve the prevention and treatment of drug abuse and addiction. Prior to his current appointment, Dr. Compton served as the Director of NIDA's Division of Epidemiology, Services and Prevention Research from 2002 until 2013. In this leadership role, he oversaw the scientific direction of a complex public health research program of national and international scope addressing: 1) the extent and spread of drug abuse, 2) how to prevention drug abuse, and 3) how to implement drug abuse prevention and treatment services as effectively as possible. Before joining NIDA, Dr. Compton was Associate Professor of Psychiatry and Director of the Master in Psychiatric Epidemiology Program at Washington University in Saint Louis as well as Medical Director of Addiction Services at the Barnes-Jewish Hospital in Saint Louis. Dr. Compton received his undergraduate education from Amherst College. He attended medical school and completed his residency training in psychiatry at Washington University. During his career, Dr. Compton has achieved multiple scientific accomplishments: he was selected to serve as a member of the DSM-5 Revision Task Force; is the author of more than 130 articles and chapters; and is an invited speaker at multiple high-impact venues. Dr. Compton is the recipient of multiple awards and in 2008, he received the Senior Scholar Health Services Research Award from the American Psychiatric Association, in 2010 the Paul Hoch Award from the American Psychopathological Association, in both 2012 and 2013, he was selected to receive the Leveraging Collaboration Award from the Food and Drug Administration. In 2013, Dr. Compton received the prestigious Health and Human Services Secretary's Award for Meritorious Service.
Does Disclose: 3M Companies: Ownership Interest includes stock, stock options, patent or other intellectual property; General Electric Co.: Ownership Interest includes stock, stock options, patent or other intellectual property Pfizer, Inc.: Ownership Interest includes stock, stock options, patent or other intellectual property.
Elisabeth Kato
MD, MRP
Elisabeth Uphoff Kato, MD, MRP, is a medical officer at the Agency for Healthcare Research and Quality in the Center for Evidence and Practice Improvement, where she coordinates AHRQ activities related to opioids and supports the National Center for Excellence in Primary Care. She previously served as medical officer to the Evidence-based Practice Center Program and the US Preventive Services Task Force at AHRQ. Prior to joining the federal government she worked as a Senior Medical Research Analyst with Hayes Inc. Before turning to medicine, Dr. Kato worked on international development projects in Nepal, Thailand, and Cambodia. Dr. Kato received medical training at the University of Maryland and has Master’s and Bachelor’s degrees from Cornell University.
Geetha A. Subramaniam
MD, DFAPA, DFAACAP
Geetha A. Subramaniam, MD, DFAPA, DFAACAP is the Deputy Director of the Center for Clinical Trials Network, at NIDA. In this role, she has been instrumental in developing research projects in a variety of topic areas, including addressing the prevention of substance abuse in adolescents, prevention and intervention of prescription stimulant misuse in youth. Previously, she was a full-time faculty member in the Division of Child Psychiatry at Johns Hopkins School of Medicine and the Associate Medical Director of Mountain Manor Treatment Center, Baltimore, MD, where she led clinical trials with adolescents with SUD and served as a preceptor to residents and fellows. She distinguished herself as a clinical and research expert in the assessment and treatment of adolescents and young adults with opioid use disorders. She is ABPN certified in General, Child, and Adolescent, and Addiction Psychiatry and a Distinguished Fellow of both the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry.
Aaron White, PhD
Leader, Epidemiology and Biometry Branch and Senior Scientific Advisor to the Director
National Institute on Alcohol Abuse and Alcoholism
Aaron White is the Senior Scientific Advisor to the Director at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). His areas of scientific expertise include the brain mechanisms and epidemiology of alcohol-induced memory blackouts, and the impact of alcohol and other drugs on brain function and behavior, particularly during the adolescent years.
Dr. White co-wrote the online alcohol prevention course, AlcoholEdu, which has been completed by more than 3 million high school and college students to date. He joined NIAAA in 2008 and, until recently, was a Program Officer in the Division of Epidemiology and Prevention Research. As a Program Officer, Dr. White oversaw a large portfolio of grants covering epidemiology and prevention research related to underage and college drinking. In 2015, he was promoted to Senior Scientific Advisor to the Director, Dr. George Koob. In this position, Dr. White advises the Director regarding a wide variety of scientific topic areas in alcohol and other drug research.
He also frequently takes part in media interviews and delivers presentations on behalf of the Institute, including presentations on addiction and overdoses at a meeting of the United Nations Office of Drugs and Crime in Austria last fall. He is an author on 37 peer-reviewed manuscripts, 22 review papers and book chapters, 3 books and has delivered several hundred presentations about alcohol and the brain.
No Relevant Financial Disclosures
CME, CE, CEU and Other Credit Types
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification / Continuing Certification Program
American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for 1.25 credits towards ABPM MOC Part II requirements.
American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 1.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.
Royal College of Physicians and Surgeons of Canada (RCPSC)
Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits.
Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
Key:
Complete
Next
Failed
Available
Locked